article thumbnail

COVID-19 Showcased Failed Global Cooperation

Bill of Health

By Kayum Ahmed, Julia Bleckner, and Kyle Knight In mid-May, the World Health Organization officially declared the “emergency” phase of the COVID-19 pandemic over.

COVID-19 299
article thumbnail

The Case for Procurement Transparency

Bill of Health

By Tara Davis and Nicola Soekoe In January 2021, the Director General of the World Health Organization (WHO) observed that the world was on the brink of a “catastrophic moral failure” if wealthier nations did not ensure the equitable distribution of COVID-19 vaccines.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why Sustainability in the Healthcare Sector Requires a Cultural Mindset Shift

Healthcare IT Today

In fact, in 2021, the World Health Organization organized a coalition of 42 countries to reduce emissions across their health systems. Sheetal has a track record of 20 years spanning management consulting, executive business management, and pharmaceutical industry experience.

article thumbnail

Is Zero Trust the Remedy to Healthcare’s Ransomware Epidemic?

HIT Consultant

In fact, the first-ever such attack targeted the industry in 1989 when 20,000 floppy disks infected with ransomware were given to those who attended the World Health Organization’s AIDS Conference. The pandemic only made the situation worse; it’s been a case of bad actors kicking the industry while it was already down.

article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

Importantly, most of the commitments made under the Open COVID Pledge were designed to expire at the end of the COVID-19 pandemic as determined by the World Health Organization (WHO) or January 1, 2023, whichever occurs first (the 2023 date is now in the process of being extended). Moderna’s Pledge. From 2020 to 2022, the U.S.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2022 – May

SQA

88, Microbial Data Deviation Investigations in the Pharmaceutical Industry, January 2022. World Health Organization (WHO). WHO Pharmaceuticals Newsletter, No. PDA Technical Report No. PDA Technical Report No. 88 presents a holistic approach for performing a microbiological investigation.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2024

SQA

It provides a practical guide for the pharmaceutical industry on how to implement PACs within the framework of an effective Pharmaceutical Quality System (PQS) and in alignment with ICH quality guidelines. the “WeFun” product is an unapproved new drug).

FDA 52